Therapeutic Targets for Age-related Macular Degeneration: Proteome-wide Mendelian Randomization and Colocalization Analyses

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 Jun 21

PMID 38903171

Authors

Kun-Lin Pu

Hong Kang

Li Li

Affiliations

Soon will be listed here.

Abstract

Background: Currently, effective therapeutic drugs for age-related macular degeneration (AMD) are urgently needed, and it is crucial to explore new treatment targets. The proteome is indispensable for exploring disease targets, so we conducted a Mendelian randomization (MR) of the proteome to identify new targets for AMD and its related subtypes.

Methods: The plasma protein level data used in this study were obtained from two large-scale studies of protein quantitative trait loci (pQTL), comprising 35,559 and 54,219 samples, respectively. The expression quantitative trait loci (eQTL) data were sourced from eQTLGen and GTEx Version 8. The discovery set for AMD data and subtypes was derived from the FinnGen study, consisting of 9,721 AMD cases and 381,339 controls, 5,239 wet AMD cases and 273,920 controls, and 6,651 dry AMD cases and 272,504 controls. The replication set for AMD data was obtained from the study by Winkler TW et al., comprising 14,034 cases and 91,234 controls. Summary Mendelian randomization (SMR) analysis was employed to assess the association between QTL data and AMD and its subtypes, while colocalization analysis was performed to determine whether they share causal variants. Additionally, chemical exploration and molecular docking were utilized to validate potential drugs targeting the identified proteins.

Results: SMR and colocalization analysis jointly identified risk-associated proteins for AMD and its subtypes, including 5 proteins (WARS1, BRD2, IL20RB, TGFB1, TNFRSF10A) associated with AMD, 2 proteins (WARS1, IL20RB) associated with Dry-AMD, and 9 proteins (COL10A1, WARS1, VTN, SDF2, LBP, CD226, TGFB1, TNFRSF10A, CSF2) associated with Wet-AMD. The results revealed potential therapeutic chemicals, and molecular docking indicated a good binding between the chemicals and protein structures.

Conclusion: Proteome-wide MR have identified risk-associated proteins for AMD and its subtypes, suggesting that these proteins may serve as potential therapeutic targets worthy of further clinical investigation.

Citing Articles

DNA methylation biomarkers and myopia: a multi-omics study integrating GWAS, mQTL and eQTL data.

Dong X, Chen D, Chen H, Li D, Hu D, Lanca C Clin Epigenetics. 2024; 16(1):157.

PMID: 39538342 PMC: 11562087. DOI: 10.1186/s13148-024-01772-1.

References

Biasella F, Plossl K, Karl C, Weber B, Friedrich U . Altered Protein Function Caused by AMD-associated Variant rs704 Links Vitronectin to Disease Pathology. Invest Ophthalmol Vis Sci. 2020; 61(14):2. PMC: 7718807. DOI: 10.1167/iovs.61.14.2. View

Chen C, Guo D, Lu G . Wogonin protects human retinal pigment epithelium cells from LPS-induced barrier dysfunction and inflammatory responses by regulating the TLR4/NF-κB signaling pathway. Mol Med Rep. 2017; 15(4):2289-2295. DOI: 10.3892/mmr.2017.6252. View

Chauquet S, Zhu Z, ODonovan M, Walters J, Wray N, Shah S . Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study. JAMA Psychiatry. 2021; 78(6):623-631. PMC: 7948097. DOI: 10.1001/jamapsychiatry.2021.0005. View

Apte R . Age-Related Macular Degeneration. N Engl J Med. 2021; 385(6):539-547. PMC: 9369215. DOI: 10.1056/NEJMcp2102061. View

Fritsche L, Lauer N, Hartmann A, Stippa S, N Keilhauer C, Oppermann M . An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet. 2010; 19(23):4694-704. DOI: 10.1093/hmg/ddq399. View

Wong W, Su X, Li X, Cheung C, Klein R, Cheng C . Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2):e106-16. DOI: 10.1016/S2214-109X(13)70145-1. View

Lee S, Liu W, Brosnan C, Dickson D . GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia. 1994; 12(4):309-18. DOI: 10.1002/glia.440120407. View

Vanamee E, Faustman D . On the TRAIL of Better Therapies: Understanding TNFRSF Structure-Function. Cells. 2020; 9(3). PMC: 7140660. DOI: 10.3390/cells9030764. View

Zhu Z, Zhang F, Hu H, Bakshi A, Robinson M, Powell J . Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016; 48(5):481-7. DOI: 10.1038/ng.3538. View

10.

Ferris 3rd F, Fine S, Hyman L . Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984; 102(11):1640-2. DOI: 10.1001/archopht.1984.01040031330019. View

11.

Ten Dijke P, Arthur H . Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol. 2007; 8(11):857-69. DOI: 10.1038/nrm2262. View

12.

Anderson D, Hageman G, Mullins R, Neitz M, Neitz J, Ozaki S . Vitronectin gene expression in the adult human retina. Invest Ophthalmol Vis Sci. 1999; 40(13):3305-15. View

13.

Sobrino A, Mata M, Laguna-Fernandez A, Novella S, Oviedo P, Garcia-Perez M . Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells. PLoS One. 2009; 4(12):e8242. PMC: 2785884. DOI: 10.1371/journal.pone.0008242. View

14.

Mahalingam D, Szegezdi E, Keane M, de Jong S, Samali A . TRAIL receptor signalling and modulation: Are we on the right TRAIL?. Cancer Treat Rev. 2009; 35(3):280-8. DOI: 10.1016/j.ctrv.2008.11.006. View

15.

Preissner K, Reuning U . Vitronectin in vascular context: facets of a multitalented matricellular protein. Semin Thromb Hemost. 2011; 37(4):408-24. DOI: 10.1055/s-0031-1276590. View

16.

Mori K, Ishikawa K, Fukuda Y, Ji R, Wada I, Kubo Y . TNFRSF10A downregulation induces retinal pigment epithelium degeneration during the pathogenesis of age-related macular degeneration and central serous chorioretinopathy. Hum Mol Genet. 2022; 31(13):2194-2206. DOI: 10.1093/hmg/ddac020. View

17.

Fritsche L, Igl W, Cooke Bailey J, Grassmann F, Sengupta S, Bragg-Gresham J . A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2015; 48(2):134-43. PMC: 4745342. DOI: 10.1038/ng.3448. View

18.

Zheng J, Haberland V, Baird D, Walker V, Haycock P, Hurle M . Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020; 52(10):1122-1131. PMC: 7610464. DOI: 10.1038/s41588-020-0682-6. View

19.

Nowak J . Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006; 58(3):353-63. View

20.

Arakawa S, Takahashi A, Ashikawa K, Hosono N, Aoi T, Yasuda M . Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet. 2011; 43(10):1001-4. DOI: 10.1038/ng.938. View